BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33454346)

  • 21. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.
    Charytan DM; Desai M; Mathur M; Stern NM; Brooks MM; Krzych LJ; Schuler GC; Kaehler J; Rodriguez-Granillo AM; Hueb W; Reeves BC; Thiele H; Rodriguez AE; Buszman PP; Buszman PE; Maurer R; Winkelmayer WC
    Kidney Int; 2016 Aug; 90(2):411-421. PubMed ID: 27259368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3).
    Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Matsumura-Nakano Y; Nakatsuma K; Watanabe H; Yamamoto E; Kato E; Fuki M; Yamaji K; Nishikawa R; Nagao K; Takeji Y; Watanabe H; Tazaki J; Watanabe S; Saito N; Yamazaki K; Soga Y; Komiya T; Ando K; Minatoya K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
    Am J Cardiol; 2021 Mar; 142():35-43. PubMed ID: 33279479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease - 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 - .
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Circ J; 2015; 79(6):1282-9. PubMed ID: 25818902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Age and Sex on Clinical Outcomes After Percutaneous Coronary Intervention Relative to Coronary Artery Bypass Grafting in Patients With Triple-Vessel Coronary Artery Disease.
    Yamaji K; Shiomi H; Morimoto T; Nakatsuma K; Toyota T; Ono K; Furukawa Y; Nakagawa Y; Kadota K; Ando K; Shirai S; Onodera T; Watanabe H; Natsuaki M; Sakata R; Hanyu M; Nishiwaki N; Komiya T; Kimura T
    Circulation; 2016 May; 133(19):1878-91. PubMed ID: 27009629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary Artery Bypass Surgery versus Percutaneous Coronary Intervention for Left Main Coronary Artery Disease with Chronic Kidney Disease.
    Lin TC; Lu TM; Huang FC; Hsu PF; Shih CC; Lin SJ; Hsu CP
    Int Heart J; 2018 Mar; 59(2):279-285. PubMed ID: 29563384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predialysis coronary revascularization and postdialysis mortality.
    Gaipov A; Molnar MZ; Potukuchi PK; Sumida K; Canada RB; Akbilgic O; Kabulbayev K; Szabo Z; Koshy SKG; Kalantar-Zadeh K; Kovesdy CP
    J Thorac Cardiovasc Surg; 2019 Mar; 157(3):976-983.e7. PubMed ID: 31431793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effectiveness analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with chronic kidney disease and unprotected left main coronary artery disease.
    Kim DW; Om SY; Park MW; Park HW; Lee PH; Kang DY; Ahn JM; Lee CW; Park SW; Park SJ; Her SH; Park DW
    EuroIntervention; 2020 May; 16(1):27-35. PubMed ID: 31380780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Hayano M; Furukawa Y; Nakagawa Y; Tazaki J; Imai M; Yamaji K; Tada T; Natsuaki M; Saijo S; Funakoshi S; Nagao K; Hanazawa K; Ehara N; Kadota K; Iwabuchi M; Shizuta S; Abe M; Sakata R; Okabayashi H; Hanyu M; Yamazaki F; Shimamoto M; Nishiwaki N; Imoto Y; Komiya T; Horie M; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Am J Cardiol; 2012 Oct; 110(7):924-32. PubMed ID: 22721575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG registry cohort-2.
    Tazaki J; Shiomi H; Morimoto T; Imai M; Yamaji K; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    EuroIntervention; 2013 Aug; 9(4):437-45. PubMed ID: 23965348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Chronic Kidney Disease on Long-Term Outcomes in Type 2 Diabetic Patients With Coronary Artery Disease on Surgical, Angioplasty, or Medical Treatment.
    Lima EG; Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Favarato D; Hueb AC; Rahmi Garcia RM; Franchini Ramires JA; Filho RK
    Ann Thorac Surg; 2016 May; 101(5):1735-44. PubMed ID: 26794894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.
    Marui A; Kimura T; Nishiwaki N; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Eur J Cardiothorac Surg; 2015 Feb; 47(2):316-21; discussion 321. PubMed ID: 24662243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis.
    Wang Z; Gong Y; Fan F; Yang F; Qiu L; Hong T; Huo Y
    Ren Fail; 2020 Nov; 42(1):107-112. PubMed ID: 31918608
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute kidney injury following coronary revascularization procedures in patients with advanced CKD.
    Gaipov A; Molnar MZ; Potukuchi PK; Sumida K; Szabo Z; Akbilgic O; Streja E; Rhee CM; Koshy SKG; Canada RB; Kalantar-Zadeh K; Kovesdy CP
    Nephrol Dial Transplant; 2019 Nov; 34(11):1894-1901. PubMed ID: 29986054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Baseline Angiographic Complexities Determined by Coronary Artery Bypass Grafting SYNTAX Score on the Prediction of Outcome After Percutaneous Coronary Intervention.
    Nakahashi T; Sakata K; Nomura A; Yakuta Y; Gamou T; Terai H; Horita Y; Ikeda M; Namura M; Takamura M; Kawashiri MA; Yamagishi M; Hayashi K
    Am J Cardiol; 2016 Oct; 118(7):974-9. PubMed ID: 27521219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of chronic kidney disease on early clinical outcomes after off-pump coronary artery bypass grafting.
    Li X; Zhang S; Xiao F
    J Cardiothorac Surg; 2020 Jul; 15(1):199. PubMed ID: 32727495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.